FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier.
about
The innate immune system in demyelinating diseaseAre Microglial Cells the Regulators of Lymphocyte Responses in the CNS?Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesThe pathobiology of vascular dementiaMHC mismatch inhibits neurogenesis and neuron maturation in stem cell allograftsImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Vitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseImmune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammationAntiapoptotic Effects of EGb 761The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasisP2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligandThe role of astrocytes in CNS tumors: pre-clinical models and novel imaging approachesAKT controls human first trimester trophoblast cell sensitivity to FAS-mediated apoptosis by regulating XIAP expression.Estrogen and microglia: A regulatory system that affects the brain.Immune function of microglia.Genome-wide genetic associations with IFNγ response to smallpox vaccineRole of microglia in glioma biology.Apoptosis of inflammatory cells in immune control of the nervous system: role of glia.Intracerebral regulation of immune responses.Estrogen, cognition and female ageing.Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis?The adaptive immune system in diseases of the central nervous system.Immune problems in central nervous system cell therapy.Death ligands and autoimmune demyelination.FasL expression on human nucleus pulposus cells contributes to the immune privilege of intervertebral disc by interacting with immunocytes.Roles of Fas and Fas ligand during mammary gland remodeling.The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71.Astrocytes in the tempest of multiple sclerosis.Life in the Fas lane: differential outcomes of Fas signaling.Immune responses to non-tumor antigens in the central nervous system.Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease.A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells.Estradiol regulates expression of polysialated neural cell adhesion molecule by human vascular endothelial cells.Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons.Regulation of Fas ligand expression by estrogen in normal ovary.Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis.The expression and role of Fas ligand in intestinal inflammation.Fas and Fas-L expression in Huntington's disease and Parkinson's disease.Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus.
P2860
Q24597958-809EA646-A0A6-493C-8A37-D484A0E741D3Q26774826-61221364-CE98-45D1-9023-F5C4D5B476BCQ26798402-CB68EC25-1D5F-4D7E-9C8E-7C4DFAFD96DBQ27006033-2C8451F1-E2AF-4D7F-A601-B32D96865CA6Q27313884-CD3E16E1-1196-49A6-8D88-6D32B81A622CQ28078539-35628BA7-613C-48C3-B1E5-3EEB598E57D4Q28081150-D6EA43C1-0358-44FF-8A4E-ABA6BF3C920EQ28298280-BC189CFE-66EB-4E5D-95C9-350563A724E1Q28387384-C5677C7F-7D57-41B2-BD2F-9515433A19E4Q30463364-0E65131E-3B71-4A93-8594-059E05F06D49Q30524208-BCA92D28-A136-4BA5-B1B2-77AD147EBF6BQ30618244-487E7C05-D965-4C84-AD35-BDF0455D3A74Q33573322-300D88D7-91EA-479F-8902-18EEDC6064ADQ33714935-5DA92335-E068-4E76-A512-6CDA2928918CQ34094707-930580CC-788C-468F-A7B6-AA3134237E75Q34221936-B01DA8A3-0DDA-45D1-AAB8-CB9D0CCEC9E0Q34309564-13E13E38-CE37-4E30-9EB6-C9F5C91A0C95Q34398617-418C6741-A9B8-439B-9B90-3F163BBE4924Q34454525-A138427E-EB77-45B4-88A5-55797B380198Q34585797-B4CD3CD9-B2C1-409A-872E-42EC1C678CD8Q34617250-8B22B5F8-2DB1-440D-8353-A44155B97914Q35858036-1057D762-2261-498D-8EF3-520CFB242A9AQ36045396-8C2EC327-209B-4F04-9585-078199BB8CABQ36535669-A9860D64-8035-4279-8D51-D50CD1FD7507Q36953140-5885F24F-E15D-4009-A724-5B088C525098Q37271091-EA497388-9016-4A3A-AE98-C1F9A0964A3BQ37442215-457091A1-2485-484B-8B08-F9234269D5B7Q37858667-A1F0945F-3681-4A1E-A347-CC3D6237624BQ38098432-15C70DDD-C06B-4070-BE24-D45F8BB1CD26Q38272285-3692EB3E-25C9-4507-AF9F-ED21C22BFF9CQ39282122-6157227B-FF14-4CF8-8034-EE1CAE045226Q39977568-88839AB1-4608-4370-A8FD-1EA002C8F8D9Q42180223-1F8C07DC-8D87-4D2E-83C8-D9EFDA83FEDBQ42921048-42577CF3-256C-4C1D-8EDB-67E465967140Q43972516-3B67E229-2303-4D01-BAB0-A0B61FCF1A5FQ44061475-E1C2EB5A-C4AA-458F-A11F-A9BBB491FD66Q44574077-D45ECF6F-5703-4ACA-8018-B3BA5DAC76FFQ44756682-53A53357-0B31-4216-9FB4-869F94F2A6BBQ45301534-27DA3540-7AB1-4729-B4C6-C3AB4FD38CF5Q48251340-80F5C84F-27DE-4D84-9BD8-3615FCE4D204
P2860
FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@en
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@nl
type
label
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@en
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@nl
prefLabel
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@en
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@nl
P2093
P2860
P1433
P1476
FasL (CD95L, Apo1L) is express ...... n immunological brain barrier.
@en
P2093
P2860
P356
10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S
P577
1999-07-01T00:00:00Z